| 產品名稱 |
VHL phage P1-191 |
| 商品貨號 |
B217485 |
| Designations |
VHL phage P1-191 |
| GenBank Number |
AF010238
|
| Depositors |
I Kuzmin |
| Vector |
Construct size (kb): 95.0 |
| Insert |
DNA: genomic Insert lengths(kb): 18.0 Tissue: renal cell carcinoma von Hippel-Lindau tumor Disease: von Hippel-Lindau tumor |
| Insert Size (kb) |
18.0 |
| Media |
ATCC Medium 1065 (see below) plus kanamycin (50 mcg/ml) ATCC Medium 1065: Tryptone (Difco 0123), 10.0 g Yeast Extract (Difco 0127), 5.0 g NaCl, 10.0 g Distilled water, 1.0 L
|
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments |
Contains VHL disease tumor suppressor gene critical region deleted in clear cell renal carcinomas and further 80kb region upstream. |
| References |
Latif F, et al. Identification of the von Hippel-Lindau disease Tumor Suppressor Gene. Science 260: 1317-1320, 1993. PubMed: 8493574
Kuzmin I, et al. One-megabase yeast artificial chromosome and 400-kilobase cosmid-phage contigs containing the von Hippel-Lindau tumor suppressor and Ca(2+)-transporting adenosine triphosphatase isoform 2 genes. Cancer Res. 54: 2486-2491, 1994. PubMed: 8162598
|
